Cargando…
Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?
Systemic corticosteroids (CSs), a keystone in pulmonology, are drugs with strong antiinflammatory activity. They are cheap, easily available, and accessible, but with common and serious side effects. Moreover, the use of exogenous CSs may suppress the hypothalamic–pituitary–adrenal (HPA) axis, predi...
Autores principales: | Melani, Andrea S., Croce, Sara, Cassai, Lucia, Montuori, Giusy, Fabbri, Gaia, Messina, Maddalena, Viani, Magda, Bargagli, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447722/ https://www.ncbi.nlm.nih.gov/pubmed/37356085 http://dx.doi.org/10.1007/s41030-023-00227-x |
Ejemplares similares
-
The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018) -
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures
por: Vantaggiato, Lorenza, et al.
Publicado: (2023) -
“Less is better” is the best message when talking to patients about alcohol
por: Rani, Savita, et al.
Publicado: (2023) -
Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021) -
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study
por: d’Alessandro, Miriana, et al.
Publicado: (2023)